Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypothalamic Obesity”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableLooking for participantsNCT07396896
What this trial is testing

KETO-TUMOR: a Study on Brain Tumors and Central Obesity

Who this might be right for
Obese PatientsHypothalamic Neoplasms
Meyer Children's Hospital IRCCS 30
Post-approval studies (Phase 4)Looking for participantsNCT06901245
What this trial is testing

Tirzepatide in PWS, HO and GNSO

Who this might be right for
Prader-Willi SyndromeHypothalamic ObesityObesity/Therapy
Grace Kim 36
Not applicableApproved For MarketingNCT05183802
What this trial is testing

An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)

Who this might be right for
Bardet-Biedl Syndrome (BBS)Obesity
Rhythm Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02860923
What this trial is testing

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

Who this might be right for
CraniopharyngiomasHypothalamic Obesity
University Hospital, Bordeaux 42
Not applicableStudy completedNCT01117272
What this trial is testing

The Relationship of PRL and Polycystic Ovary Syndrome (PCOS) in Taiwan's Women

Who this might be right for
Polycystic Ovary Syndrome
Taipei Medical University WanFang Hospital 474
Large-scale testing (Phase 3)Study completedNCT03746522
What this trial is testing

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Alström Syndrome (AS)
Rhythm Pharmaceuticals, Inc. 52
Not applicableStudy completedNCT05626907
What this trial is testing

Does What You Eat Affect Your Brain

Who this might be right for
GliosisObesityEating
University of Washington 36
Not applicableUnknownNCT05237440
What this trial is testing

Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State.

Who this might be right for
Obesity
University Hospital, Limoges 102
Not applicableStudy completedNCT00688987
What this trial is testing

The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation

Who this might be right for
ObesityAddison's Disease
Oregon Health and Science University 24
Testing effectiveness (Phase 2)Study completedNCT04725240
What this trial is testing

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Who this might be right for
Hypothalamic Obesity
Rhythm Pharmaceuticals, Inc. 18
Not applicableUnknownNCT04634929
What this trial is testing

Endocrinological and Neuronal Aspects of Bariatric Surgery

Who this might be right for
Bariatric SurgeryObesity
University of Heidelberg Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT03845075
What this trial is testing

48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

Who this might be right for
Hypothalamic Injury-induced Obesity (HIO)
Saniona 21
Testing effectiveness (Phase 2)Study completedNCT06046443
What this trial is testing

Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

Who this might be right for
Hypothalamic Obesity
Rhythm Pharmaceuticals, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00675506
What this trial is testing

Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

Who this might be right for
Abdominal ObesityGrowth Hormone Deficiency
Massachusetts General Hospital 60
Not applicableWithdrawnNCT02441491
What this trial is testing

Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )

Who this might be right for
ROHHAD Syndrome
Johns Hopkins University
Large-scale testing (Phase 3)Study completedNCT04966741
What this trial is testing

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency ObesityPCSK1 Deficiency Obesity+1 more
Rhythm Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT02232919
What this trial is testing

Deep Brain Stimulation for Human Morbid Obesity

Who this might be right for
Obesity
Hospital do Coracao 6
Not applicableStudy completedNCT05400278
What this trial is testing

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Oslo University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02063295
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Who this might be right for
ObesityOver-weightHypothalamic Injury+1 more
Zafgen, Inc. 14
Not applicableStudy completedNCT03479437
What this trial is testing

The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry

Who this might be right for
Genetic Forms of Extreme Obesity
Rhythm Pharmaceuticals, Inc. 303
Load More Results